Drugs / Cortex Phellodendri compound fluid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06985589 | Jan → Aug 2024 | herpes zoster | Second Affiliated Hospital of Xi'an Jiaotong University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cortex Phellodendri compound fluid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06985589 ↗ |
| Known as | CPCF | “For the Chinese herbal wet compress treatment, CPCF (Shandong Hanfang Pharmaceutical Co., LTD.) was decocted using forsythia, honeysuckle, phellodendron, dandelion, and centipede.” NCT06985589 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese herbal wet compress treatment” NCT06985589 ↗ |
| Route | Topical | “the gauze was applied to the lesion for 15 minutes/time, 3 times a day, for 10 days.” NCT06985589 ↗ |